glp 1 alzheimer Could diabetes and weight loss drugs treat Alzheimer's disease? GLP-1 improves the neuronal supportive
Description
Recently, the introduction of highly effective glucagon-like peptide-1 (GLP-1) receptor agonists has led to increased utilization of obesity medications in this population
Learn what it is, why people are trying it to lower side effects and cost, and how to do it safely, effectively, step by step.
Improvement in care, especially in early stages, is crucial
Doctor's Tips
Importantly, large-scale randomized trials, meta-analyses, and observational studies suggest that GLP-1RAs do not significantly increase AKI risk and may even confer renal benefits in high-risk populations
